Corbus Pharmaceuticals Holdings, Inc. Annual Nonoperating Income (Expense) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Corbus Pharmaceuticals Holdings, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2013 to 2023.
  • Corbus Pharmaceuticals Holdings, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $1.72M.
  • Corbus Pharmaceuticals Holdings, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $7.52M.
  • Corbus Pharmaceuticals Holdings, Inc. annual Nonoperating Income (Expense) for 2023 was $474K.
  • Corbus Pharmaceuticals Holdings, Inc. annual Nonoperating Income (Expense) for 2022 was -$2.51M, a 124% decline from 2021.
  • Corbus Pharmaceuticals Holdings, Inc. annual Nonoperating Income (Expense) for 2021 was $10.3M, a 10.3% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.